Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
Lemaire, Maryse, Chabot, Guy G, Raynal, Noël Jm, Momparler, Louise F, Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L
Published in BMC cancer (02.05.2008)
Published in BMC cancer (02.05.2008)
Get full text
Journal Article
Targeting of cancer stem cells by inhibitors of DNA and histone methylation
Momparler, Richard L, Côté, Sylvie
Published in Expert opinion on investigational drugs (03.08.2015)
Published in Expert opinion on investigational drugs (03.08.2015)
Get more information
Journal Article
Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer
Get full text
Journal Article
Conference Proceeding
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
Momparler, Richard L, Côté, Sylvie, Momparler, Louise F, Idaghdour, Youssef
Published in Clinical epigenetics (01.10.2014)
Published in Clinical epigenetics (01.10.2014)
Get full text
Journal Article
Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells
Momparler, Richard L, Côté, Sylvie, Momparler, Louise F, Idaghdour, Youssef
Published in Frontiers in oncology (15.02.2017)
Published in Frontiers in oncology (15.02.2017)
Get full text
Journal Article